However, the pattern differs: Ozempic Tends to Cause: More nausea at initiation Constipation is more common than diarrhea Ozempic face (facial fat loss) more discussed in patient communities Mounjaro Tends to Cause: More diarrhea than constipation Slightly higher rates of vomiting at higher doses Appetite suppression described as more complete by patients What the Data Shows The takeaway : Individual response varies dramatically
No significant effects were observed in rats at a dose of 50 units/kg/day and in rabbits at a dose of 3 units/kg/day
If finalized, semaglutide, tirzepatide, and liraglutide would be formally excluded from the 503B bulks list on a finding of no clinical need, meaning outsourcing facilities could not compound these drugs from bulk substances even if nominated to the list
Thinking about this reminds me of a patient I heard about who ordered a cheaper pen from a social post, then experienced severe stomach pain and a rash that wasnt typical for their past experience with the legitimate product a worrying red flag
AquaVita provides access to compounded medications for eligible patients
And then there are weeks like this